| Author |
Title |
JournalName |
Year D |
| Click on Column Headers to Re-Sort The Current List |
| Pennes HH |
Clinical reactions of schizophrenics to sodium amytal, pervitin hydroc... |
J. Nerv. Ment. Dis. |
1954 |
| Fischer R, Agnew N |
On drug-produced experimental psychoses |
Naturwissenschaften |
1954 |
| Fabing HD |
New blocking agent against the development of LSD-25 psychosis. |
Science |
1955 |
| Tonini G, Montanari C |
Effects of Experimentally Induced Psychoses on Artistic Expression |
Confinia neurol. |
1955 |
| Brown BB, Braun D, Feldma... |
The pharmacologic activity of (4-piperidyl)-benzhydrol hydrochloride (... |
J. Pharmacol. Exper.... |
1956 |
| Pennes HH |
Effects of various drugs on clinical psychopathology |
Experimental psychop... |
1957 |
| Weiss B, Abramson HA, Bar... |
Lysergic acid diethylamide (LSD-25). XXV. Effect of potassium cyanid... |
Arch. Neurol. & Psyc... |
1958 |
| Friedhoff AJ, Lynn FA, Ro... |
Preliminary study of a new anti-depressant drug |
J Nerv Ment Dis |
1958 |
| Loeb C, Giberti F |
Lysergic acid diethylamide effects modified by hydroxyzine hydrochlori... |
Confinia neurol. |
1959 |
| Himwich HE, van Meter WG,... |
An EEG analysis of psychotomimetic drugs. |
Neuro-Psychopharmaco... |
1959 |
| LE Hollister, JJ Prusmack... |
Comparison of three psychotropic drugs (Psilocybin, JB-329, and IT-290... |
J. Nerv. & Ment. Dis... |
1960 |
| Cohen BD, Rosenbaum G, Lu... |
Comparison of phencyclidine hydrochloride (Sernyl) with other drugs. ... |
Arch. gen.Psychiat. |
1962 |
| DELAHUNT CS, O'CONNOR RA,... |
Toxic retinopathy following prolonged treatment with dl-p-trifluoromet... |
Toxicol Appl Pharmac... |
1963 |
| Uyeno ET |
Hallucinogenic compounds and swimming response |
J. Pharmacol.exp.The... |
1968 |
| Kofod B |
Iron, copper, and zinc in rat brain |
Europ. J. Pharmacol |
1970 |
| Holman RG, Shillito EE, V... |
Sleep produced by clonidine (2-(2,6-dichlorophenylamino)- 2-imidazolin... |
Brit. J. Pharmacol. |
1971 |
| Gaston TR, Rasmussen GT |
Identification of 3,4 methylenedioxymethamphetamine |
Bureau of Narcotics ... |
1972 |
| Bailey K |
The mass spectra of dimethoxyamphetamine hydrochlorides |
Anal Chim Acta |
1972 |
| Nichols DE, Barfknecht CF... |
Asymmetric synthesis of psychotomimetic phenylisopropylamines |
J Med Chem |
1973 |
| Barasi S, Roberts MHT |
The action of 5-hydroxytryptamine antagonists and precursors on bulbo-... |
Brain Res |
1973 |
| Baker RW, Chothia C, Paul... |
Molecular structures hallucinogenic substances: lysergic acid diethyla... |
Molec. Pharmacol. |
1973 |
| Cooper PD |
Beta-chloroethylamines related to mescaline |
J Med Chem |
1973 |
| Fuller RW, Snoddy HD |
Long-term effects of 4-chloroamphetamine on brain 5-hydroxyindole meta... |
Neuropharmacology |
1974 |
| Bailey K, Legault D, Vern... |
Drugs, Spectroscopic and chromatographic identification of dimethoxyam... |
J Assoc Off Anal Che... |
1974 |
| Stone TW |
Further evidence for a dopomine receptor stimulating action of an ergo... |
Brain Research |
1974 |
| Munch JC |
Phencyclidine: pharmacology and toxicology |
Bulletin on Narcotic... |
1974 |
| Griffith JD, Nutt JG, Jas... |
A comparison of fenfluramine and amphetamine in man |
Clin Pharmacol Ther |
1975 |
| Masoud A N |
Systematic Identification of Drugs of Abuse I: Spot Tests |
J.Pharm.Sci. |
1975 |
| Holz WC, Gill CA |
Drug Injections as Negative Reinforcers. |
Pharmacol.Rev. |
1975 |
| Fuller RW, Perry KW, Moll... |
Reversible and irreversible phases of serotonin depletion by 4-chloroa... |
Eur J Pharmacol |
1975 |
| Shulgin, A. |
Profiles of Psychedelic Drugs: TMA-2 |
Journal of Psychoact... |
1976 |
| Quock RM, Beal GA, Chant ... |
Quipazine: a serotoninergic hyperthermic agent in the rabbit |
J.Pharm.Pharmacol. |
1976 |
| Masoud AN |
Systematic Identification of Drugs of Abuse II: TLC |
J.Pharm.Sci. |
1976 |
| Ovcharov R, Bantoutova I,... |
Pharmacological Analysis of Certain Mecharisms of Morphine Addiction |
Acta Physiol.Pharmac... |
1976 |
| Shulgin, A. |
Profiles of Psychedelic Drugs: MMDA |
Journal of Psychoact... |
1976 |
| Shulgin, A. |
Profiles of Psychedelic Drugs: STP |
Journal of Psychoact... |
1977 |
| Briggs I |
Excitatory Responses of Neurones in Rat Bulbar Reticular Formation to ... |
J.Physiol. |
1977 |
| Menon MK, Clark WG, Masuo... |
Possible Involvement of the Central Dopaminergic System in the Antires... |
Psychopharmacology |
1977 |
| Schwarcz R, Bennett JP, C... |
Loss of striatal serotonin synaptic receptor binding induced by kainic... |
J.Neurochem. |
1977 |
| Pardanani JH, McLaughlin ... |
Cactus Alkaloids. XXXVI. Mescaline and related compounds from Trichoce... |
Lloydia |
1977 |
| Nichols DE |
Phenethylamine Hallucinogens: New Structural Analogy and Implications ... |
Life Sci. |
1978 |
| Carroll ME, France CP, Me... |
Food deprivation increases oral and intravenous drug intake in rats |
Science |
1979 |
| Nielsen EB, Lee TH, Ellis... |
Following Several Days of Continuous Administration d-Amphetamine Acqu... |
Psychopharmacology |
1980 |
| Alexander BK, Beyerstein ... |
Effect of early and later colony housing on oral ingestion of morphine... |
Pharmacol Biochem Be... |
1981 |
| Ferrigni NR, Nichols DE, ... |
Cactus alkaloidsXLVIIN alpha-dimethylhistamine, a hypotensive componen... |
J Ethnopharmacol |
1982 |
| Brouwer JN, Glaser D, Har... |
The sweetness-inducing effect of miraculin; behavioural and neurophysi... |
J Physiol |
1983 |
| Boulton AA, Davis BA |
The metabolism of ingested deuterium-labelled p-tyramine in normal sub... |
Biomed Environ Mass ... |
1987 |
| Beeghly JH, Kuperman S, P... |
Fenfluramine treatment of autism: relationship of treatment response t... |
J Autism Dev Disord |
1987 |
| Oberlender R, Nichols DE |
Drug discrimination studies with MDMA and amphetamine |
Psychopharmacology (... |
1988 |
| Klein RFX, Sperling AR, C... |
The Stereoisomers of 4-Methylaminorex |
Journal of Forensic ... |
1989 |
| Nichols DE, Oberlender R |
Structure-activity relationships of MDMA and related compounds: a new ... |
Ann N Y Acad Sci |
1990 |
| Oberlender R, Nichols DE |
(+)-N-methyl-1-(1,3-benzodioxol-5-yl)-2-butanamine as a discriminative... |
J Pharmacol Exp Ther |
1990 |
| Dedeo?lu A, Fisher LA |
Central and peripheral injections of the 5-HT2 agonist, 1-2,5-dimethox... |
J Pharmacol Exp Ther |
1991 |
| Marchant NC, Breen MA, Wa... |
Comparative biodisposition and metabolism of 14C-(+/-)-fenfluramine in... |
Xenobiotica |
1992 |
| Harvey JA, McMaster SE, R... |
Methylenedioxyamphetamine: Neurotoxic effects on serotonergic projecti... |
Brain Res |
1993 |
| Volkow ND, Ding YS, Fowle... |
Is methylphenidate like cocaine? Studies on their pharmacokinetics and... |
Arch Gen Psychiatry |
1995 |
| Monte AP, Waldman SR, Mar... |
Dihydrobenzofuran analogues of hallucinogens. 4. Mescaline derivatives |
J Med Chem |
1997 |
| Morimoto BH, Lovell S, Ka... |
Ecstasy: 3,4-methylenedioxymethamphetamine (MDMA) |
Acta Crystallogr C |
1998 |
| Ahmed JM, Salame MY, Oakl... |
Chest pain in a young girl |
Postgrad Med J |
1998 |
| Nagayama T, Sinor AD, Sim... |
Cannabinoids and neuroprotection in global and focal cerebral ischemia... |
J Neurosci |
1999 |
| Deleuze-Masquefa C, Micha... |
1-[1-(2-Benzo[b]thiopheneyl)cyclohexyl]piperidine hydrochloride (BTCP)... |
Eur J Pharm Sci |
2000 |
| Berman RM, Cappiello A, A... |
Antidepressant effects of ketamine in depressed patients |
Biol Psychiatry |
2000 |
| Behan WMH, Madigan M, Cla... |
Muscle changes in the neuroleptic malignant syndrome |
J Clin Pathol |
2000 |
| Lee GS, Taylor RC, Dawson... |
High-resolution solid state 13C nuclear magnetic resonance spectra of ... |
Solid State Nucl Mag... |
2000 |
| Brunnenberg M, Kovar KA |
Stereospecific analysis of ecstasy-like N-ethyl-3,4-methylenedioxyamph... |
J Chromatogr B Biome... |
2001 |
| Quail MT, Weimersheimer P... |
Abuse of telazol: an animal tranquilizer |
J Toxicol Clin Toxic... |
2001 |
| Jenks CW |
Extraction studies of Tabernanthe iboga and Voacanga africana |
Nat Prod Lett |
2002 |
| Jenks CW |
Extraction studies of Tabernanthe iboga and Voacanga africana |
Nat Prod Lett |
2002 |
| Smith KM, Larive LL, Roma... |
Club drugs: methylenedioxymethamphetamine, flunitrazepam, ketamine hyd... |
Am J Health Syst Pha... |
2002 |
| Taffe MA, Davis SA, Yuan ... |
Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to s... |
Neuropsychopharmacol... |
2002 |
| Schepers RJ, Oyler JM, Jo... |
Methamphetamine and amphetamine pharmacokinetics in oral fluid and pla... |
Clin Chem |
2003 |
| Simonsen KW, Kaa E, Niels... |
Narcotics at street level in Denmark. A prospective investigation from... |
Forensic Sci Int |
2003 |
| Carter JF, Sleeman R, Par... |
The distribution of controlled drugs on banknotes via counting machine... |
Forensic Sci Int |
2003 |
| Boys A, Marsden J |
Perceived functions predict intensity of use and problems in young pol... |
Addiction |
2003 |
| Buechler J, Schwab M, Mik... |
Enantioselective quantitation of the ecstasy compound R- and S-N-ethyl... |
J Chromatogr B Analy... |
2003 |
| Dubowchik GM, Michne JA, ... |
An efficient sequence for the preparation of small secondary amine hyd... |
Bioorg Med Chem Lett |
2004 |
| Ootsuka Y, Nalivaiko E, B... |
Spinal 5-HT2A receptors regulate cutaneous sympathetic vasomotor outfl... |
Brain Res |
2004 |
| Piper BJ, Vu HL, Safain M... |
Repeated adolescent 3,4-methylenedioxymethamphetamine (MDMA) exposure ... |
J Pharmacol Exp Ther |
2006 |
| Zarate CA, Singh JB, Carl... |
A Randomized Trial of an N-methyl-D-aspartate Antagonist in Treatment-... |
Arch Gen Psychiatry |
2006 |
| Griffiths RR, Richards WA... |
Psilocybin can occasion mystical-type experiences having substantial a... |
Psychopharmacology (... |
2006 |
| Kamata HT, Shima N, Zaits... |
Metabolism of the recently encountered designer drug, methylone, in hu... |
Xenobiotica |
2006 |
| Kolbrich EA, Barnes AJ, G... |
Major and minor metabolites of cocaine in human plasma following contr... |
J Anal Toxicol |
2006 |
| Beynon CM, Sumnall HR, Mc... |
The ability of two commercially available quick test kits to detect dr... |
Addiction |
2006 |
| Stanwood GD, Levitt P |
Prenatal exposure to cocaine produces unique developmental and long-te... |
J Neurosci |
2007 |
| Shahani R, Streutker C, D... |
Ketamine-associated ulcerative cystitis: a new clinical entity |
Urology |
2007 |
| Anand JS, Glebocka ML, Ko... |
Recreational abuse with benzydamine hydrochloride (tantum rosa) |
Clin Toxicol (Phila) |
2007 |
| Fucci N |
Unusual adulterants in cocaine seized on Italian clandestine market |
Forensic Sci Int |
2007 |
| Salem EA, Wilson SK, Biss... |
Tramadol HCL has promise in on-demand use to treat premature ejaculati... |
J Sex Med |
2008 |
| Deakin JF, Lees J, McKie ... |
Glutamate and the neural basis of the subjective effects of ketamine: ... |
Arch Gen Psychiatry |
2008 |
| Uhl GR, Liu QR, Drgon T, ... |
Molecular Genetics of Successful Smoking Cessation: Convergent Genome-... |
Arch Gen Psychiatry |
2008 |
| Gryniewicz CM, Reepmeyer ... |
Detection of undeclared erectile dysfunction drugs and analogues in di... |
J Pharm Biomed Anal |
2009 |
| Maheux CR, Copeland CR, P... |
Characterization of Three Methcathinone Analogs: 4-Methylmethcathinone... |
Microgram Journal |
2010 |
| Wood DM, Stribley V, Darg... |
Variability in the 3,4-methylenedioxymethamphetamine content of 'ecsta... |
Emerg Med J |
2011 |
| Goli V, Webster LR, Lamso... |
Effects of concurrent intravenous morphine sulfate and naltrexone hydr... |
Harm Reduct J |
2012 |
| Kavanagh P, O'Brien J, Po... |
'Smoking' mephedrone: The identification of the pyrolysis products of ... |
Drug Test Anal |
2012 |
| Litjens RP, Brunt TM |
How toxic is ibogaine? |
Clin Toxicol (Phila) |
2016 |
| Botticelli MP, Koh HK |
Changing the Language of Addiction |
JAMA |
2016 |
| Anderson L, Bell HG, Gilb... |
Using Social Listening Data to Monitor Misuse and Nonmedical Use of Bu... |
JMIR Public Health S... |
2017 |
| Barsuglia JP, Polanco M, ... |
A case report SPECT study and theoretical rationale for the sequential... |
Prog Brain Res |
2018 |
